Wednesday, March 25, 2009 1:49:48 PM
We know our technology works, however I'm less convinced our management does...JMHO
Krays...the stent market is rapdily expanding and evolving eventually BIPH's licenses with BSX will begin to generate royalty revenues...the question is...will there be a company left to receive those revenues?
Note the new Extent drug eluting stent recently received the CE mark for Europe...a desperately needed stent and yet Extent's financial viability remains in doubt...sound familiar...JMHO
I maintain a core position however my faith in the competency of Biophan's management is waning...JMHO
live and let live...
ole bub and the dawgs
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM